Authors


Stephanie L. Freed, PharmD

Latest:

Raising the Bar Through Education and Quality Initiatives

From its creation, Diplomat University at Diplomat Specialty Pharmacy has been structured around its primary objective to provide a high-level of ongoing education to enable staff and partners to take the best possible care of patients.


Kiernan Taylor & Rachel Jennings, PharmD Candidates

Latest:

How Diet and Lifestyle Modifications Can Improve Cognitive Function in the Elderly

Select foods, vitamins, and cardiovascular activity have all been proven in clinical literature to be essential components of improving the health of our encephala.


Aileen Ahiskali, PharmD, BCIDP

Latest:

Choose the Most Appropriate Therapy to Fight Influenza

Baloxavir marboxil and oseltamivir are options for treating uncomplicated influenza.


Eleanor Hayes-Larson, MPH

Latest:

Daily Dose and Costs of Therapy With Topical Testosterone Agents

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.


Jipan Xie, MD, PhD

Latest:

Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension

A large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.


With Theresa Tolle, DeAnn Mullins

Latest:

Women at the Forefront of Pharmacy

Three female leaders in pharmacy discuss the changes in this industry.


Taylor R. Elliot, PharmD/MPH candidate

Latest:

COVID-19 and Telehealth: Will the Expansion Persist After the Pandemic?

A temporary public policy change and insurers' expanded benefits have allowed the growth of telehealth services during the COVID-19 pandemic.


Amanda Manoogian, PharmD, BCOP, Clinical Pharmacy Coordinator Specialty Pharmacy - Clinical Services (Partners Healthcare)

Latest:

Oral Therapies for Hormone Receptor – Positive Breast Cancers

The recent development of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, as well as alpelisib (Piqray), a phosphoinositide 3-kinase (PI3K) inhibitor, has changed the way patients with HR-positive MBC are treated.


Curtis E. Haas , PharmD, FCCP

Latest:

Unsung Heroes: Recognizing the Vital Role of Pharmacy Informaticists in Health Care

These employees build operational workflows, predictive analytical tools, implement and refine clinical decision support technologies, increase efficiency, and more.



Laurie W. Amirpoor, PharmD

Latest:

Analyzing the Impact of Different Value-Based Insurance Design Programs

Total 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.


Emily C. Hayes, PharmD Candidate

Latest:

What Is the Best Way to Get Rid of a Cough?

Before recommending any OTC cough suppressants, pharmacists must remind patients to consult a medical professional before giving these medications to children younger than 4 years.


Betty Lu, PharmD

Latest:

Pharmacists and Annual Wellness Visits

Pharmacists are continuing to expand their role as health care providers with more direct patient care opportunities. Pharmacists working under the supervision of a physician can provide an annual wellness visit, which is an exam that focuses on the patient’s health, allowing them the opportunity to develop a personalized approach to health care and disease prevention.


Susan M. Spivey, PharmD, DDS

Latest:

Utility of the PhaSeal Closed System Drug Transfer Device

The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.



Ryan Farrington, PharmD, BCPS

Latest:

Maximizing Electronic Medical Records: The Electronic Medical Record Adoption Model and the Health-System Pharmacist

There is growing confidence that health information technology investments will begin to meet expectations.


Becky A. Briesacher, PhD

Latest:

Impact of Initial Days' Supply of Angiotensin II Receptor Blockers

For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.


Shawn X. Sun, PhD

Latest:

Examining Part D Beneficiaries' Medication Use in the Doughnut Hole

The authors found that the Part D doughnut hole significantly reduced the use of medications for treating potentially disabling and life-threatening conditions, but increased out-of-pocket costs for Medicare beneficiaries.


Todd Cooperman, PharmD, RPh, PAHM

Latest:

Challenges and Opportunities with Oral Oncology Agents

Pharmacists can collaborate with oncologists to maximize patient outcomes through appropriate dispensing, side-effect monitoring, and adherence.



Hiangkiat Tan, BPharm, MS

Latest:

Real-World Dosing and Utilization of Ustekinumab Among Patients With Psoriasis

This study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.



Anna M. Roe, MSN, RN

Latest:

Infection Specialists and Pharmacists Share Responsibility for Ensuring Patient Safety

Collaboration Is a necessary component of successful compliance with USP , and technology can help.


Anita T. Shaffer

Latest:

Pomalidomide Labeled an Advance in Multiple Myeloma

The combination of pomalidomide and a steroid significantly improved outcomes for patients with multiple myeloma who have exhausted other novel therapies, marking what researchers say is a notable advancement for a sizable proportion of those treated for the disease.


Michael S. Monaghan, PharmD

Latest:

Lifestyle Modifications for Patients with Metabolic Syndrome

Pharmacists are in a unique position to inform patients about the various features and proper use of blood pressure monitors.


Julie Kelly, 2017 PharmD Candidate

Latest:

Going Above and Beyond as Pharmacists

Learn more about what it's like to work for a Walgreens specialty pharmacy.




Nicholas Karalis, RPh

Latest:

Bullied into Extinction

Government involvement may be required in order to keep corporate entities from bullying specialty pharmacies out of business.


The Center for Biosimilars Staff

Latest:

FDA OKs Biosimilar Adalimumab for Autoimmune Conditions

The FDA has approved Sandoz’s biosimilar adalimumab, Hyrimoz (adalimumab-adaz) for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn disease, ulcerative colitis, and plaque psoriasis.

© 2024 MJH Life Sciences

All rights reserved.